These 4 Measures Indicate That Alcon (VTX:ALC) Is Using Debt Reasonably Well
May 28
Swiss (SMI) Healthcare Sector Analysis
UpdatedMay 29, 2024
DataAggregated Company Financials
Companies35
- 7D-1.9%
- 3M1.2%
- 1Y-6.7%
- YTD2.2%
Over the last 7 days, the Healthcare industry has dropped 1.9%, driven by Novartis declining 2.2%. Overall the industry is down 6.7% in 12 months. Looking forward, earnings are forecast to grow by 13% annually.
Sector Valuation and Performance
Has the Swiss Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 30 May 2024 | CHF552.2b | CHF150.1b | CHF22.9b | 33.5x | 24.1x | 3.7x |
| Sat, 27 Apr 2024 | CHF537.3b | CHF146.2b | CHF22.8b | 35.3x | 23.5x | 3.7x |
| Mon, 25 Mar 2024 | CHF534.6b | CHF144.2b | CHF22.2b | 37.5x | 24x | 3.7x |
| Wed, 21 Feb 2024 | CHF528.2b | CHF142.8b | CHF22.4b | 32.5x | 23.6x | 3.7x |
| Fri, 19 Jan 2024 | CHF541.3b | CHF152.6b | CHF21.9b | 27.3x | 24.7x | 3.5x |
| Sun, 17 Dec 2023 | CHF522.0b | CHF152.7b | CHF21.9b | 27.2x | 23.8x | 3.4x |
| Tue, 14 Nov 2023 | CHF506.0b | CHF154.9b | CHF22.2b | 23.7x | 22.8x | 3.3x |
| Thu, 12 Oct 2023 | CHF540.2b | CHF154.0b | CHF21.7b | 28.4x | 24.9x | 3.5x |
| Sat, 09 Sep 2023 | CHF538.2b | CHF144.7b | CHF21.2b | 29.4x | 25.4x | 3.7x |
| Mon, 07 Aug 2023 | CHF549.4b | CHF143.3b | CHF21.1b | 35.3x | 26x | 3.8x |
| Wed, 05 Jul 2023 | CHF562.6b | CHF147.2b | CHF22.2b | 35.5x | 25.3x | 3.8x |
| Fri, 02 Jun 2023 | CHF575.7b | CHF147.9b | CHF22.3b | 35.2x | 25.8x | 3.9x |
| Sun, 30 Apr 2023 | CHF573.3b | CHF146.9b | CHF22.3b | 32.1x | 25.7x | 3.9x |
| Tue, 28 Mar 2023 | CHF542.7b | CHF147.4b | CHF22.2b | 42.3x | 24.5x | 3.7x |
| Thu, 23 Feb 2023 | CHF550.4b | CHF148.3b | CHF22.8b | 34.9x | 24.2x | 3.7x |
| Sat, 21 Jan 2023 | CHF567.8b | CHF148.3b | CHF38.0b | 31.5x | 14.9x | 3.8x |
| Mon, 19 Dec 2022 | CHF565.9b | CHF149.0b | CHF38.2b | 30.4x | 14.8x | 3.8x |
| Wed, 16 Nov 2022 | CHF574.6b | CHF149.4b | CHF38.4b | 32.9x | 15x | 3.8x |
| Fri, 14 Oct 2022 | CHF561.2b | CHF153.3b | CHF40.8b | 26.7x | 13.8x | 3.7x |
| Sun, 11 Sep 2022 | CHF585.2b | CHF150.7b | CHF39.8b | 25.9x | 14.7x | 3.9x |
| Tue, 09 Aug 2022 | CHF601.1b | CHF149.5b | CHF39.6b | 31.7x | 15.2x | 4x |
| Thu, 07 Jul 2022 | CHF595.1b | CHF149.3b | CHF40.6b | 31.3x | 14.7x | 4x |
| Sat, 04 Jun 2022 | CHF607.2b | CHF148.8b | CHF40.3b | 31.8x | 15x | 4.1x |
| Mon, 02 May 2022 | CHF647.2b | CHF148.8b | CHF40.4b | 37.4x | 16x | 4.4x |
| Wed, 30 Mar 2022 | CHF668.2b | CHF145.7b | CHF39.2b | 40.9x | 17.1x | 4.6x |
| Fri, 25 Feb 2022 | CHF620.3b | CHF144.9b | CHF39.0b | 36.8x | 15.9x | 4.3x |
| Sun, 23 Jan 2022 | CHF650.9b | CHF138.7b | CHF25.1b | 46.6x | 25.9x | 4.7x |
| Tue, 21 Dec 2021 | CHF679.8b | CHF139.2b | CHF25.2b | 46.3x | 27x | 4.9x |
| Thu, 18 Nov 2021 | CHF693.3b | CHF138.8b | CHF25.2b | 48.2x | 27.6x | 5x |
| Sat, 16 Oct 2021 | CHF677.0b | CHF137.4b | CHF24.3b | 48.4x | 27.9x | 4.9x |
| Mon, 13 Sep 2021 | CHF674.4b | CHF137.5b | CHF24.3b | 48.5x | 27.8x | 4.9x |
| Wed, 11 Aug 2021 | CHF711.4b | CHF137.4b | CHF24.2b | 54.3x | 29.4x | 5.2x |
| Sun, 06 Jun 2021 | CHF610.8b | CHF134.7b | CHF22.9b | 50.4x | 26.7x | 4.5x |
Price to Earnings Ratio
26.7x
Current Industry PE
- Investors are relatively neutral on the Swiss Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 22.1x.
- The industry is trading close to its 3-year average PS ratio of 4.1x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 3.7% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Trends
Which industries have driven the changes within the Swiss Healthcare sector?
| CH Market | -0.95% | |
| Healthcare | -1.87% | |
| Biotech | 5.11% | |
| Healthcare Services | 3.53% | |
| Medical Equipment | 1.40% | |
| Healthtech | 1.39% | |
| Pharma | -2.51% | |
| Life Sciences | -2.64% | |
Industry PE
- Investors are most optimistic about the Life Sciences industry, which is trading close to its 3-year average PE ratio of 50.9x.
- Analysts are expecting annual earnings growth of 18.2%, which is higher than its past year's earnings growth of 6.5% per year.
Forecasted Growth
- Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 18% over the next 5 years.
- This is better than its past earnings growth rate of 6.5% per year.
- In contrast, the Healthcare Services industry is expected to see its earnings grow by 7.2% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| GALE Galenica | CHF73.00 | 2.7% +CHF97.2m | 2.7% | PE22.1x | |
| DESN Dottikon ES Holding | CHF263.00 | 1.5% +CHF55.1m | 1.5% | PE42.1x | |
| AEVS Aevis Victoria | CHF15.65 | 2.3% +CHF29.5m | -15.9% | PS1.6x | |
| IDIA Idorsia | CHF2.35 | 4.2% +CHF16.8m | -68.5% | PS3x | |
| MOVE Medacta Group | CHF123.00 | 0.5% +CHF12.0m | 9.8% | PE52.4x |
